[dralley]

>Remdesivir has a minor beneficial impact when delivered VERY EARLY.

There's still a couple of problems though:

* It has to be delivered by IV drip

* It's in short supply

* It's expensive

Which means that realistically, the only way to get a positive impact from it would be to send high-risk patients who were very likely to have just been exposed to the hospital for the injection. Even then, the risk-value proposition does not seem that great.

[koheripbal]

None of these three points is the bottleneck. It's still easy to give someone an IV early on if they're in a high-risk group, it's not in that short supply, and at ~$2500 per treatment regimen it's not that expensive compared to an extended hospital stay.

The bottleneck is that it's only slightly effective.

[ulfw]

It’ll be a means for the rich to lessen their pain. Nothing more. Let’s be honest.

No hospital would take you in on slight symptoms. The drug alone costs $3,000+, it’s basically US-only and thus needs to be administered there, which will end up costing about as much again.

See the top 0.01% hold some remdesivir in their mansions for their private physician to administer.